Charles C. Rovetti
Pfizer (United States)(US)
Publications by Year
Research Areas
Receptor Mechanisms and Signaling, Nicotinic Acetylcholine Receptors Study, Neurotransmitter Receptor Influence on Behavior, Cannabis and Cannabinoid Research, Synthesis and Biological Evaluation
Most-Cited Works
- → Varenicline: An α4β2 Nicotinic Receptor Partial Agonist for Smoking Cessation(2005)930 cited
- → Pharmacological profile of the α4β2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid(2006)533 cited
- → Effects of the cannabinoid CB1 receptor antagonist SR141716A on the behavior of pigeons and rats(1996)134 cited
- → Effects of the competitive nicotinic antagonist erysodine on behavior occasioned or maintained by nicotine: comparison with mecamylamine(2000)50 cited
- → The role of monoamine neurotransmitter systems in the nicotine discriminative stimulus(1998)38 cited
- → CP-135,807, a selective 5-HT 1D agonist: effects in drug discrimination and punishment procedures in the pigeon(1996)7 cited
- → Low efficacy partial agonists of the α4β2 nicotinic acetylcholine receptor (nAChR). Does functional efficacy govern in vivo response?(2009)1 cited